Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioelectronics Corp BIEL

BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and... see more

Recent & Breaking News (PINL:BIEL)

BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio

GlobeNewswire July 23, 2018

BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain

GlobeNewswire July 12, 2018

BioElectronics Corporation’s President Andy Whelan Joins Everett Jolly on “Stock Day” to Discuss Progress

GlobeNewswire June 13, 2018

B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program

GlobeNewswire May 31, 2018

BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application

GlobeNewswire May 29, 2018

BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application

GlobeNewswire May 11, 2018

BioElectronics to Meet with FDA To Seek Expanded OTC Clearances

GlobeNewswire May 2, 2018

BioElectronics Announces Knee Replacement Clinical Study

GlobeNewswire March 19, 2018

BioElectronics Vice President of Sales Discusses Opioids and the Alternative Drug Free ActiPatch® Pain Therapy

GlobeNewswire January 22, 2018

BioElectronics Announces Expanded Menstrual Pain Study

GlobeNewswire January 16, 2018

BioElectronics and CARE Pharmacies to Provide Pain Consultations and ActiPatch, the Drug Free Alternative to Opioids

GlobeNewswire January 9, 2018

BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

GlobeNewswire January 4, 2018

BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids

GlobeNewswire December 12, 2017

BioElectronics Announces the Launch of the ‘Try & Tell’ Program

GlobeNewswire December 7, 2017

Andy Whelan, President BioElectronics Updates Uptick Newswire “Stock Day” Listeners

GlobeNewswire November 20, 2017

BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

Marketwired November 13, 2017

BioElectronics to Showcase Products at World's Largest Medical Tradeshow

Marketwired November 9, 2017

BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)

Marketwired November 6, 2017

BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

Marketwired October 16, 2017

BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

Marketwired September 25, 2017